HVTN 129/HPTN 088

A phase 1 clinical trial to evaluate the safety, tolerability, pharmacokinetics, and functional activity of a trispecific antibody, SAR441236, in healthy, HIV-1–uninfected adult participants

Study Summary
Trispecific antibody

Graphic created by the HIV Vaccine Trials Network (HVTN)